1. Home
  2. CISO vs KALA Comparison

CISO vs KALA Comparison

Compare CISO & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CISO Global Inc.

CISO

CISO Global Inc.

N/A

Current Price

$0.23

Market Cap

13.2M

Sector

Technology

ML Signal

N/A

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

N/A

Current Price

$0.52

Market Cap

13.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CISO
KALA
Founded
2015
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
13.3M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
CISO
KALA
Price
$0.23
$0.52
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$31.50
AVG Volume (30 Days)
228.4K
353.5K
Earning Date
05-15-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
79.31
67.39
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.07
52 Week High
$1.48
$20.58

Technical Indicators

Market Signals
Indicator
CISO
KALA
Relative Strength Index (RSI) 46.48 30.22
Support Level $0.21 $0.10
Resistance Level $0.32 $0.72
Average True Range (ATR) 0.02 0.09
MACD 0.00 0.00
Stochastic Oscillator 54.47 2.92

Price Performance

Historical Comparison
CISO
KALA

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity compliance and is a software firm composed of trained and seasoned security professionals. The services are used to protect clients' data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in the U.S., Chile, and all other countries. The maximum revenue is generated from the U.S. The products and services include: security managed services, professional services, and cybersecurity software.

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: